DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Experimentally calibrated multiscale model predicts schedule dependent drug combination effects
Therapeutic synergy emerges from interactions between molecular drug action, intracellular signaling, and tissue-level transport dynamics. We developed a multiscale model integrating these scales to predict schedule-dependent drug combination effect in the AGS cell line. Calibrated solely on single-drug growth curves, the model accurately predicted population-level outcomes of drug combinations without combination-specific training. This demonstrates the model’s capacity to suggest mechanistic multiscale insights into the logic of drug combinations within the AGS cell line, establishing a computational platform for the systematic in silico exploration of virtual multiscale experiments on drug diffusion and dosing schedules. Cross-scale analysis revealed that combination therapy efficacy flows across scales: population-level pharmacokinetics dictate the sequence of molecular target engagement within individual cells, determining collective cell-fate decisions. Our simulations predict that inhibiting the PI3K/AKT axis before MEK is more effective than the reverse order, disabling a pro-survival rebound and locking cells into an apoptotic state. Ultimately, by capturing phenomena that single-scale approaches cannot, this framework generates translationally relevant hypotheses, providing a versatile platform for optimizing drug scheduling, formulation, and combination strategies where matched molecular Boolean models and phenotypic data are available., This work was supported by the European Union’s Horizon Europe Research and Innovation programme projects HANAMI (grant agreement No. 101136269), by the Horizon 2020 projects CREXDATA (grant agreement No. 101092749) and PerMedCoE (grant agreement No. 951773) and by the ERA PerMed project Oncologics (ERAPERMED2020-036). O.H.M. was supported by a predoctoral “AGAUR-FI Joan Oró” fellowship from “Secretaria d’Universitats i Recerca del Departament de Recerca i Universitats de la Generaliat de Catalunya i del Fons Europeu Social Plus” (2025 FI-1 01021)., Peer reviewed